• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    Jan 16, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Patent dispute: Delhi High Court gives a boost to access to affordable medicines

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Menghaney - Patent dispute - ...
    Size:
    127.6Kb
    Format:
    PDF
    Description:
    Main article
    Download
    Authors
    Menghaney, Leena
    Affiliation
    Medecins Sans Frontieres-Campaign for Access to Essential Medicines, C 236 Defence Colony, New Delhi, India
    Issue Date
    2010-04-01
    Submitted date
    2013-06-20
    
    Metadata
    Show full item record
    Journal
    Indian Journal of Medical Ethics
    Abstract
    The Delhi High Court has rejected the petition filed by Bayer Corporation seeking to stop the Drugs Controller of India (DCGI) from registering a generic version of a patented cancer drug. The case was filed in 2008 by Bayer to try and introduce "patent linkage" which involves linking the registration (marketing approval) of drugs with their patent status. If Bayer's plea for "patent linkage" had been accepted by the court, it would have undermined public health safeguards contained in India's patent legislation. This comment discusses the Bayer case in the context of efforts by multinational pharmaceutical companies to introduce barriers to generic competition, the only proven means of reducing the prices of medicines to make them affordable to those in need. Bayer has filed an appeal in the Supreme Court, indicating that it does not intend to give up.
    Publisher
    Forum for Medical Ethics Society
    URI
    http://hdl.handle.net/10144/302753
    PubMed ID
    20432882
    Additional Links
    http://www.ijme.in/about.html
    Language
    en
    ISSN
    0974-8466
    Collections
    Health Politics

    entitlement

    Related articles

    • Access to medicine and the dangers of patent linkage: lessons from Bayer Corp v. Union of India.
    • Authors: Tsui M
    • Issue date: 2011 Mar
    • Is India ready to lead the battle for fair access to medicines?
    • Authors: Lancet Oncology
    • Issue date: 2013 May
    • Novartis challenges India's drug patent laws in Supreme Court.
    • Authors: Billingsley M
    • Issue date: 2012 Feb 21
    • India's patent laws under pressure.
    • Authors: Roderick P, Pollock AM
    • Issue date: 2012 Sep 15
    • Taking TRIPS to India--Novartis, patent law, and access to medicines.
    • Authors: Mueller JM
    • Issue date: 2007 Feb 8
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.